Not intended for human or veterinary use
Please contact your healthcare provider for professional medical advice, specific dosage instructions, and a personalized treatment plan
In the Phase 2 obesity trial it produced about 24% weight loss at 12 mg over 48 weeks, the most of any drug in the class, and it cut liver fat by 86% in the people who started with fatty liver. In the 80-week Phase 3 obesity trial of 2,300 adults with an average BMI of 40, 12 mg produced 28% weight loss and 9 mg reached 26%
While semaglutide offers significant benefits for weight loss and diabetes management, its impact on the gastrointestinal system, including delayed gastric emptying, can interfere with nutrient absorption
Increased concentration of transcobalamin I in a patient with metastatic carcinoma of the breast
If you need products associated with Canadian supply, the Canada country-of-origin browsing area may help with broader store navigation